before and after melanotan beauty product dubbed the 'Barbie drug' sparks urgent health warnings ON YOUR SIDE: Dermatologist warns

A clinician can provide a personalized timeline

Moran, T

Afamelanotide (MT-1's INN) has narrow clinical approval in some jurisdictions for a specific dermatological condition

Institutional Review Board Statement The CHHRS and the present study were conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Anhui Medical University (protocol code: CH1049, June 2018)

The size, volume, and proliferative activity of UF were significantly reduced when patients took 1.2 g of curcumin orally every day for 6 months, with no adverse effects observed (Sukonthanonta, 2015)

(PubMed) Braekke K, Ueland PM, Harsem NK, Karlsen A, Blomhoff R, Staff AC